Effects of morphine and methadone treatments on glutamatergic transmission in rat frontal cortex

Bartosz Bobula1, Grzegorz Hess

  • 1Department of Physiology, Institute of Pharmacology, Polish Academy of Sciences, Smetna 12, PL 31-343 Kraków, Poland.

Insights

Repeated morphine, but not methadone, pretreatment specifically reduced cortical glutamatergic transmission. A subsequent morphine challenge dose further decreased AMPA/kainate and NMDA receptor activity in rat brain slices.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Neurochemistry

Background:

  • Opioid analgesics like morphine and methadone are widely used.
  • Understanding their long-term effects on brain function is crucial.
  • Glutamatergic neurotransmission plays a key role in brain activity.

Purpose of the Study:

  • To investigate the specific effects of repeated morphine or methadone administration on cortical glutamatergic transmission.
  • To examine the impact of challenge doses of these opioids after repeated pretreatment.

Main Methods:

  • Ex vivo electrophysiological recordings from rat frontal cortical slices.
  • Repeated administration of morphine (10 mg/kg) or methadone (2.5 mg/kg) for seven days.
  • Challenge doses of morphine (5 mg/kg) or methadone (2.5 mg/kg) administered after a 14-day washout period.

Main Results:

  • Repeated morphine pretreatment followed by a morphine challenge significantly decreased both AMPA/kainate and NMDA components of evoked field potentials.
  • This specific effect was not observed when a methadone challenge was used after morphine pretreatment.
  • Neither morphine nor methadone challenge doses affected these glutamatergic components after repeated methadone pretreatment.

Conclusions:

  • Repeated morphine administration followed by a morphine challenge specifically alters cortical glutamatergic transmission.
  • Methadone does not produce the same specific alterations in cortical glutamatergic transmission.
  • These findings highlight differential neurochemical effects of chronic morphine and methadone exposure.

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...